-+ 0.00%
-+ 0.00%
-+ 0.00%

Taysha Gene Therapies FY 2025 R&D expenses rise 30.91% to USD 86.4 million, net loss widens to USD 109 million

Reuters·03/19/2026 12:02:12

Please log in to view news